Noticeable pain and stiffness reduction is commonly reported after 1–2 weeks
Properties, context & comparison
The deeper view: what Revit Arthro is, how it is meant to be used, and how it compares to other approaches.
Revit Arthro delivers a one-month oral course (2 x 500 mL, 30 mL daily) with a high-dose hyaluronic acid and chondroitin complex designed for effective absorption and distribution to multiple joints.
Noticeable pain and stiffness reduction is commonly reported after 1–2 weeks
Supports synovial fluid viscosity and lubrication function
Hyaluronic acid supports chondrocyte activity; chondroitin supports cartilage structure
Quality made in Germany (GRAMME-REVIT GmbH, Grammetal)
Liquid dosage helps avoid dissolution issues common with powders and capsules
Monthly cure: 2 × 500 mL bottles, 30 mL daily use
Hyaluronic acid naturally declines with age. Our liquid formula is designed to support lubrication, cushioning, and daily mobility as part of your routine.
Daily liquid hyaluronic acid helps offset the decline that often begins around age 30.
Supports synovial fluid viscosity so movement stays smooth and cushioned inside the joint.
Helps maintain the protective fluid layer that reduces friction and stress on cartilage.
Chondroitin pairs with HA to nourish structural tissue and help maintain elasticity.
Designed for a daily month-long routine; many users report improved comfort within 1–2 weeks.
One pleasant 30 mL oral dose—no injections—engineered to reach multiple joints systemically.
| Feature | Revit Arthro (Oral) | Injections | Capsules / Powders |
|---|---|---|---|
| Administration | Pleasant daily oral use (30 mL) | Painful, invasive procedure | Requires swallowing larger doses daily |
| Monthly hyaluronic acid amount | ~6600 mg per monthly cure* | ~240 mg over typical 4-injection course* | Varies by formula and solubility |
| Coverage | Supports systemic joint routine | Local effect at injected joint | Systemic, but dissolution can limit uptake |
| Practicality | No doctor appointment needed for intake | Procedure + additional doctor costs | Convenient format, but not liquid-first |
| Typical monthly treatment cost (reference) | 160-190 EUR (German reference) | 200-350 EUR + doctor costs (German reference) | Product-dependent |
| Absorption context | Liquid dosage form engineered for uptake | No GI dissolution step | Potential GI dissolution/solubility limitations for HA |
| Source data note | * Values and costs shown are taken from the Revit Arthro Information and Comparison PDF reference provided. | ||